Celldex Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Celldex Therapeutics Inc
TickerCLDX
CIK #0000744218
CUSIP15117B202
SectorLife Sciences - In Vitro & In Vivo Diagnostic Substances
Address119 Fourth Ave, Needham, MA 02494
Source [EDGAR]
CIK Filing 2011 - 2025
[0000744218] 10-K
[0000744218] 10-Q
[0000744218] 3
[0000744218] 4
[0000744218] 8-K
[0000744218] D
[0000744218] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Point72 Asset Management LP Celldex Therapeutics Inc [2025-07-10] 0.0
Commodore Capital LP Celldex Therapeutics Inc [2025-04-10] 0.0
Price T Rowe Associates Inc /MD/ Celldex Therapeutics Inc [2025-02-14] 0.0
Kynam Capital Management LP Celldex Therapeutics Inc [2024-02-14] 5.5
Eventide Asset Management LLC Celldex Therapeutics Inc [2024-02-14] 6.64
Polar Capital Holdings PLC Celldex Therapeutics Inc [2024-02-13] 5.73
Point72 Asset Management LP Celldex Therapeutics Inc [2023-11-20] 6.6
Wellington Management Group LLP Celldex Therapeutics Inc [2023-02-06] 0.87
Viking Global Investors LP Celldex Therapeutics Inc [2022-06-10] 5.1
State Street Corp Celldex Therapeutics Inc [2022-02-10] 5.07
Vanguard Group Inc Celldex Therapeutics Inc [2022-02-09] 5.17
BlackRock Inc Celldex Therapeutics Inc [2022-02-04] 6.6
FMR LLC Celldex Therapeutics Inc [2021-10-12] 0.0
Cowen Financial Products LLC Celldex Therapeutics Inc [2021-02-25] 5.0939
Redmile Group LLC Celldex Therapeutics Inc [2021-02-16] 6.9
Logos Global Management LP Celldex Therapeutics Inc [2020-10-22] 4.3
Adage Capital Partners GP LLC Celldex Therapeutics Inc [2020-07-24] 5.01
Biotechnology Value Fund L P Celldex Therapeutics Inc [2020-06-26] 3.8
RTW Investments LP Celldex Therapeutics Inc [2020-06-19] 0.95
Ikarian Capital LLC Celldex Therapeutics Inc [2020-06-18] 7.1
Renaissance Technologies LLC Celldex Therapeutics Inc [2020-02-12] 6.91
Columbia Wanger Asset Management LLC Celldex Therapeutics Inc [2017-02-10] 5.1
KLP Enterprises LLC Celldex Therapeutics Inc [2016-12-09] 5.7
State Street Corp Celldex Therapeutics Inc [2016-04-08] 8.67
First Trust Portfolios LP Celldex Therapeutics Inc [2016-01-27] 7.53
Vanguard Group Inc Celldex Therapeutics Inc [2014-02-12] 5.59
Franklin Resources Inc Celldex Therapeutics Inc [2014-02-11] 0.0
FMR LLC Celldex Therapeutics Inc [2013-09-10] 0.0
SAC Capital Advisors LP Celldex Therapeutics Inc [2013-04-22] 4.9
SAC Capital Advisors LP Celldex Therapeutics Inc [2013-04-05] 4.9
Prudential Financial Inc Celldex Therapeutics Inc [2013-02-13] 5.9
Jennison Associates LLC Celldex Therapeutics Inc [2013-02-11] 5.7
BlackRock Inc Celldex Therapeutics Inc [2013-01-30] 8.65
Ridgeback Capital Investments LP Celldex Therapeutics Inc [2012-12-28] 6.1
Form 3/4/5 Filer 2011 - 2025
Jimenez Freddy A.
Celldex Therapeutics, Inc.
Cavanaugh Sarah
Heath-Chiozzi Margo
Martin Samuel Bates
Crowley Elizabeth
Neil Garry Arthur
Conrad Herbert J
Marucci Anthony S
Torres Denice
Jain Rita
Penner Harry Jr
Cohen Cheryl
Brownlie Keith L
Pepin Ronald
Young Diane C.
Keler Tibor
Marino James J
Wright Richard M.
Shoos Karen L.
McMahon Gerald PhD
Ellberger Larry
Davis Thomas Andrew
LaVallee Theresa
Catlin Avery W
van den Broek Richard
Elston George
Shannon Timothy M
Form 13F Holdings
Firm Period DFND Voting Shares
Kynam Capital Management LP [2025-06-30] SOLE 6,100,729 6,100,729
BlackRock, Inc. [2025-06-30] SOLE 5,324,712 5,550,016
FMR LLC [2025-06-30] DFND 5,434,732 5,439,118
Wellington Management Group LLP [2025-06-30] DFND 0 5,232,326
Vanguard Group Inc [2025-06-30] SOLE 0 3,852,637
Commodore Capital LP [2025-06-30] SOLE 3,450,000 3,450,000
Bellevue Group AG [2025-06-30] DFND 3,307,569 3,307,569
Point72 Asset Management LP [2025-06-30] DFND 0 2,801,721
State Street Corp [2025-06-30] DFND 2,219,399 2,405,495
Deep Track Capital LP [2025-06-30] SOLE 2,000,000 2,000,000
Vestal Point Capital LP [2025-06-30] SOLE 1,750,000 1,750,000
Geode Capital Management LLC [2025-06-30] DFND 1,672,980 1,672,980
Woodline Partners LP [2025-06-30] SOLE 1,500,455 1,500,455
Eventide Asset Management LLC [2025-06-30] SOLE 1,356,186 1,356,186
Pictet Asset Management Holding SA [2025-06-30] SOLE 1,164,748 1,300,329
Polar Capital Holdings Plc [2025-06-30] DFND 1,228,435 1,228,435
Novo Holdings A/S [2025-06-30] SOLE 1,200,000 1,200,000
UBS Group AG [2025-06-30] DFND 841,171 841,246
Eversept Partners LP [2025-06-30] SOLE 838,736 838,736
Fisher Asset Management LLC [2025-06-30] DFND 266,240 822,208
Rock Springs Capital Management LP [2025-06-30] SOLE 812,653 812,653
American Century Companies Inc [2025-06-30] DFND 666,688 779,985
Goldman Sachs Group Inc [2025-06-30] DFND 724,886 727,504
Baker Bros Advisors LP [2025-06-30] SOLE 665,370 665,370
Morgan Stanley [2025-06-30] DFND 639,684 661,518
D. E. Shaw & Co., Inc. [2025-06-30] DFND 640,957 645,657
Logos Global Management LP [2025-06-30] SOLE 600,000 600,000
Northern Trust Corp [2025-06-30] DFND 565,851 565,851
Charles Schwab Investment Management Inc [2025-06-30] SOLE 553,081 553,081
5AM Venture Management LLC [2025-06-30] SOLE 497,270 497,270
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com